There are several treatments available for Alzheimer’s disease, aimed at managing symptoms and potentially slowing its progression. These include cholinesterase inhibitors (such as donepezil, rivastigmine, and galantamine) and memantine, which regulate neurotransmitters involved in memory and learning. Additionally, lifestyle interventions like cognitive stimulation and physical exercise may offer some benefits. Experimental treatments like monoclonal antibodies targeting amyloid plaques and tau protein are under investigation. The cerebrolysin 10ml, a neurotrophic agent, has shown promise in some studies for improving cognitive function. However, its efficacy requires further research and validation through clinical trials.